Douglas A. Jabs

25.0k total citations · 3 hit papers
286 papers, 16.5k citations indexed

About

Douglas A. Jabs is a scholar working on Ophthalmology, Epidemiology and Rheumatology. According to data from OpenAlex, Douglas A. Jabs has authored 286 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Ophthalmology, 102 papers in Epidemiology and 58 papers in Rheumatology. Recurrent topics in Douglas A. Jabs's work include Ocular Diseases and Behçet’s Syndrome (203 papers), Retinal and Optic Conditions (91 papers) and Cytomegalovirus and herpesvirus research (91 papers). Douglas A. Jabs is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (203 papers), Retinal and Optic Conditions (91 papers) and Cytomegalovirus and herpesvirus research (91 papers). Douglas A. Jabs collaborates with scholars based in United States, United Kingdom and India. Douglas A. Jabs's co-authors include James T. Rosenbaum, Robert B. Nussenblatt, Jennifer E. Thorne, James P. Dunn, John H. Kempen, Grace A. Levy-Clarke, C. Stephen Foster, Gary N. Holland, Sanjay Kedhar and Mark L. Van Natta and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Douglas A. Jabs

278 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop

2005 3.2k citations Douglas A. Jabs, Robert B. Nussenblatt et al. American Journal of Ophthalmology profile →
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

2000 722 citations Douglas A. Jabs, James T. Rosenbaum et al. American Journal of Ophthalmology profile →
Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders

2013 330 citations Grace A. Levy-Clarke, Douglas A. Jabs et al. Ophthalmology profile →

Peers

Countries citing papers authored by Douglas A. Jabs

Since Specialization

Citations

This map shows the geographic impact of Douglas A. Jabs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Jabs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Jabs more than expected).

Fields of papers citing papers by Douglas A. Jabs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Jabs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Jabs. The network helps show where Douglas A. Jabs may publish in the future.

Co-authorship network of co-authors of Douglas A. Jabs

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Jabs. A scholar is included among the top collaborators of Douglas A. Jabs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Jabs. Douglas A. Jabs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial 2025 ·Ophthalmology ·Douglas A. Jabs, Elizabeth A. Sugar, Alyce Burke, Michael M. Altaweel, Jennifer E. Thorne, Sheriza Baksh, Lyndell L. Lim, Akshay S. Thomas, Steven Yeh, (unknown)	0
2	Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6 2025 ·American Journal of Ophthalmology ·Marion R. Munk, (unknown), (unknown), Lee M. Jampol, Maria Vittoria Cicinelli, Phoebe Lin, Kathryn L. Pepple, K. Bailey Freund, İlknur Tuğal-Tutkun, (unknown), (unknown), Sapna Gangaputra, Rupesh Agrawal, Douglas A. Jabs, Srinivas R. Sadda, David Sarraf, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
3	Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis—Multimodal Imaging in Uveitis (MUV) Taskforce Report 5 2025 ·American Journal of Ophthalmology ·(unknown), (unknown), (unknown), Edmund Tsui, Jennifer E. Thorne, Alejandra de‐la‐Torre, Michael M. Altaweel, Jyotirmay Biswas, Srinivas R. Sadda, Alessandro Invernizzi, Rupesh Agrawal, Jessica G. Shantha, Massimo Accorinti, Amani A. Fawzi, Douglas A. Jabs, David Sarraf, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
4	Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes 2023 ·American Journal of Ophthalmology ·Douglas A. Jabs, Elizabeth A. Sugar, Alyce Burke, Michael M. Altaweel, James P. Dunn, Sapna Gangaputra, John H. Kempen, Kathryn L. Pepple, Richard Stawell, Janet T. Holbrook	2
5	APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection 2021 ·Communications Biology ·Ping An, Efe Sezgın, Gregory D. Kirk, Priya Duggal, (unknown), George W. Nelson, Sophie Limou, Mark L. Van Natta, Douglas A. Jabs, Michelle M. Estrella, Jeffrey B. Kopp, Cheryl A. Winkler	5
6	Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop 2021 ·AIDS Research and Human Retroviruses ·Asante R. Kamkwalala, Ankita Garg, Upal Roy, (unknown), José Castillo‐Mancilla, Jordan E. Lake, Giada Sebastiani, Michael T. Yin, Todd T. Brown, Angela R. Kamer, Douglas A. Jabs, Ronald J. Ellis, Marta Boffito, Meredith Greene, (unknown), Eugenia L. Siegler, Kristine M. Erlandson, David J. Moore	3
7	Hierarchical Cluster Analysis of Serum and Vitreous Cytokines in Intermediate, Posterior and Panuveitis 2020 ·Investigative Ophthalmology & Visual Science ·David Dao, (unknown), Sapna Gangaputra, Pradeep K. Dagur, Susan Vitale, Douglas A. Jabs, J. Philip McCoy, H. Nida Sen	1
8	Birdshot Chorioretinitis: Treatment & Remission Outcomes 2019 ·Investigative Ophthalmology & Visual Science ·(unknown), (unknown), Douglas A. Jabs, Jennifer E. Thorne	1
9	Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases. 2019 ·Investigative Ophthalmology & Visual Science ·John H. Kempen, Craig Newcomb, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, James T. Rosenbaum, H. Nida Sen, Eric B. Suhler, Jennifer E. Thorne, Nirali Bhatt, Jeanine M. Buchanich	1
10	Visual Acuity Outcome over Time in Non-Infectious Uveitis 2019 ·Ocular Immunology and Inflammation ·Maxwell Pistilli, Marshall M. Joffe, Sapna Gangaputra, Siddharth S. Pujari, Douglas A. Jabs, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, H. Nida Sen, Eric B. Suhler, Jennifer E. Thorne, Nirali Bhatt, C. Stephen Foster, (unknown), (unknown), Kurt Dreger, Michael M. Altaweel, Janet T. Holbrook, John H. Kempen, (unknown)	20
11	Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis 2015 ·Ophthalmology ·(unknown), John H. Kempen, Michael M. Altaweel, Lea T. Drye, Janet T. Holbrook, Douglas A. Jabs, Elizabeth A. Sugar	65
12	Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis 2015 ·Ocular Immunology and Inflammation ·(unknown), Elisabetta Miserocchi, Jennifer E. Thorne, Dana M. Hornbeak, Douglas A. Jabs, Manfred Zierhut	6
13	Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis 2014 ·Investigative Ophthalmology & Visual Science ·Srishti Kothari, Maxwell Pistilli, C. Stephen Foster, H. Nida Sen, Eric B. Suhler, Jennifer E. Thorne, Douglas A. Jabs, Robert B. Nussenblatt, James T. Rosenbaum, John H. Kempen	0
14	Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis 2014 ·Investigative Ophthalmology & Visual Science ·Ebenezer Daniel, Maxwell Pistilli, H. Nida Sen, Eric B. Suhler, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Robert B. Nussenblatt, James T. Rosenbaum, John H. Kempen	1
15	Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial 2014 ·Investigative Ophthalmology & Visual Science ·John H. Kempen, Mark L. Van Natta, Michael M. Altaweel, James P. Dunn, Douglas A. Jabs, Susan Lightman, Jennifer E. Thorne, Janet T. Holbrook	1
16	Optical Coherence Tomography Imaging of Presumed Sarcoid Retinal and Optic Nerve Nodules 2014 ·Ocular Immunology and Inflammation ·Naomi R. Goldberg, Douglas A. Jabs, (unknown)	12
17	Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome—Bench to Bedside: LXVII Edward Jackson Memorial Lecture 2010 ·American Journal of Ophthalmology ·Douglas A. Jabs	103
18	Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study 2009 ·BMJ ·John H. Kempen, Ebenezer Daniel, James P. Dunn, C. Stephen Foster, Sapna Gangaputra, Asaf Hanish, Kathy J. Helzlsouer, Douglas A. Jabs, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Teresa L. Liesegang, Craig Newcomb, Robert B. Nussenblatt, (unknown), J. T. Rosenbaum, (unknown), Jessica E Thorne	124
19	Visual Acuity Loss Among Patients With AIDS and CMV Retinitis in the Era of Highly Active Antiretroviral Therapy (HAART) 2006 ·Investigative Ophthalmology & Visual Science ·Jennifer E. Thorne, Douglas A. Jabs, John H. Kempen, Janet T. Holbrook, Charles W. Nichols, Curtis L. Meinert	0
20	IMMUNOSUPPRESSION FOR POSTERIOR UVEITIS 2005 ·Retina ·Douglas A. Jabs, Esen K. Akpek	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact